封面
市場調查報告書
商品編碼
1616350

紅藤葉萃取物市場機會、成長促進因素、產業趨勢分析和 2024 年至 2032 年預測

Red Vine Leaf Extract Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年,全球紅藤葉萃取物市場價值為 69 億美元,預計在消費者對其健康益處的認知不斷提高的推動下,2024 年至 2032 年複合年成長率為 3.9%。紅藤葉萃取物因其豐富的類黃酮和多酚含量而聞名,因其強大的抗發炎和抗氧化特性而備受讚譽。由於技術進步,該行業現在提取了更高品質的紅藤葉萃取物,標準化了活性化合物含量。這種增強激起了製藥和營養保健品公司的興趣。

此外,北美和歐洲等地區也收緊了品質控制措施和監管標準。因此,競爭日益激烈,公司將資源投入研發,以符合監管要求和消費者偏好。整個產業分為產品類型、形式、應用、配銷通路和地區。 2023 年,紅藤葉萃取物粉狀市場價值為23 億美元,預計2024 年至2032 年複合年成長率為4.8%。其配方的多功能性和無縫整合到不同的產品中。

這種粉末形式在將補充劑添加到飲料或冰沙中的消費者中特別受歡迎。紅藤葉萃取物市場的膳食補充劑部分到2023 年價值26 億美元,預計2024 年至2032 年將以4.4% 的複合年成長率成長。特性和心血管支持而備受推崇,使其成為針對老年人和有生活方式相關健康問題的人的首選產品。製藥業經常在膠囊和片劑中使用紅藤葉萃取物,特別是用於解決慢性靜脈功能不全和相關的血管問題。 2023年,北美紅藤葉萃取物市場預計將達到19億美元,預計複合年成長率為4.1%。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 69 億美元
預測值 97 億美元
複合年成長率 3.9%

北美市場的快速擴張很大程度上歸功於人們對天然保健品意識的不斷增強以及對預防保健的重視。該地區對營養保健品和膳食補充劑的強勁需求使其成為紅藤葉萃取物生產商的主要市場。此外,監管機構,特別是 FDA,在塑造這些市場動態方面發揮關鍵作用,實施嚴格的監管以確保產品的安全性和有效性。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
    • 主要製造商
    • 經銷商
    • 全行業利潤率
  • 產業影響力
    • 成長動力
    • 市場挑戰
    • 市場機會
      • 新機遇
      • 成長潛力分析
  • 原料景觀
    • 製造趨勢
    • 技術演進
      • 永續製造
        • 綠色實踐
        • 脫碳
    • 原料的永續性
    • 價格趨勢(美元/噸),2021 - 2032
  • 法規和市場影響
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場規模與預測:依產品類型,2021-2032 年

  • 主要趨勢
  • 有機紅藤葉萃取物
  • 常規紅藤葉萃取物

第 6 章:市場規模與預測:按形式分類,2021-2032 年

  • 主要趨勢
  • 粉末
  • 液體
  • 膠囊
  • 平板電腦

第 7 章:市場規模與預測:按應用分類,2021-2032 年

  • 主要趨勢
  • 膳食補充劑
  • 藥品
    • 膠囊和片劑
    • 局部應用
  • 化妝品及個人護理品
  • 食品和飲料
  • 其他

第 8 章:市場規模與預測:按配銷通路分類,2021-2032 年

  • 主要趨勢
  • 直銷
  • 藥局和藥局
  • 健康與保健商店
  • 超市/大賣場
  • 網路零售
  • 其他

第 9 章:市場規模與預測:按地區分類,2021-2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • MEA
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • MEA 的其餘部分

第 10 章:公司簡介

  • Indena SpA
  • Hangzhou GreenSky Biological Technology Co., Ltd
  • Activ'Inside
  • Xi'an Haoze Biotechnology Co., Ltd.
  • Croda International Plc
  • Actives Ltd
  • LAC Global Pte. Ltd.
簡介目錄
Product Code: 11265

The Global Red Vine Leaf Extract Market was valued at USD 6.9 billion in 2023, and projections indicate a growth rate of 3.9% CAGR from 2024 to 2032, fueled by heightened consumer awareness of its health benefits. Celebrated for its rich flavonoid and polyphenol content, red vine leaf extract is lauded for its potent anti-inflammatory and antioxidant properties. Thanks to technological advancements, the industry now extracts higher-quality red vine leaf extracts, standardizing active compound levels. This enhancement has piqued the interest of pharmaceutical and nutraceutical companies.

Furthermore, regions like North America and Europe have tightened their quality control measures and regulatory standards. As a result, the landscape has become increasingly competitive, with companies pouring resources into research and development to align with both regulatory mandates and consumer preferences. The overall industry is divided into product type, form, application, distribution channel, and region. In 2023, the powdered segment of the red vine leaf extract market was valued at USD 2.3 billion, with expectations of a 4.8% CAGR from 2024 to 2032. Powdered red vine leaf extract is a mainstay in dietary supplements and functional foods, prized for its versatility in formulations and seamless integration into diverse products.

This powdered form is particularly popular among consumers who incorporate supplements into drinks or smoothies. Valued at USD 2.6 billion in 2023, the dietary supplements segment of the red vine leaf extract market is projected to grow at a 4.4% CAGR from 2024 to 2032. Within dietary supplements, the extract is prized for its circulation-boosting properties and cardiovascular support, making it a preferred choice for products targeting older adults and those with lifestyle-related health issues. The pharmaceutical industry often utilizes red vine leaf extract in capsules and tablets, especially for addressing chronic venous insufficiency and related vascular concerns. In 2023, North America red vine leaf extract market is projected to reach USD 1.9 billion, with an anticipated growth rate of 4.1% CAGR.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$6.9 Billion
Forecast Value$9.7 Billion
CAGR3.9%

The swift expansion of North America market is largely attributed to a growing awareness of natural health products and a strong emphasis on preventive healthcare. The region's strong demand for nutraceuticals and dietary supplements makes it a key market for red vine leaf extract producers. Moreover, regulatory bodies, especially the FDA, play a pivotal role in shaping these market dynamics, imposing strict regulations to ensure product safety and efficacy.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Key manufacturers
    • 3.1.2 Distributors
    • 3.1.3 Profit margins across the industry
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Market challenges
    • 3.2.3 Market opportunity
      • 3.2.3.1 New opportunities
      • 3.2.3.2 Growth potential analysis
  • 3.3 Raw material landscape
    • 3.3.1 Manufacturing trends
    • 3.3.2 Technology evolution
      • 3.3.2.1 Sustainable manufacturing
        • 3.3.2.1.1 Green practices
        • 3.3.2.1.2 Decarbonization
    • 3.3.3 Sustainability in raw materials
    • 3.3.4 Pricing trends (USD/Ton), 2021 - 2032
      • 3.3.4.1 North America
      • 3.3.4.2 Europe
      • 3.3.4.3 Asia Pacific
      • 3.3.4.4 Latin America
      • 3.3.4.5 Middle East & Africa
  • 3.4 Regulations & market impact
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Product Type, 2021-2032 (USD Billion, Tons)

  • 5.1 Key trends
  • 5.2 Organic red vine leaf extract
  • 5.3 Conventional red vine leaf extract

Chapter 6 Market Size and Forecast, By Form, 2021-2032 (USD Billion, Tons)

  • 6.1 Key trends
  • 6.2 Powder
  • 6.3 Liquid
  • 6.4 Capsules
  • 6.5 Tablets

Chapter 7 Market Size and Forecast, By Application, 2021-2032 (USD Billion, Tons)

  • 7.1 Key trends
  • 7.2 Dietary Supplements
  • 7.3 Pharmaceuticals
    • 7.3.1 Capsules & Tablets
    • 7.3.2 Topical Applications
  • 7.4 Cosmetics & Personal Care
  • 7.5 Food & Beverages
  • 7.6 Others

Chapter 8 Market Size and Forecast, By Distribution Channel, 2021-2032 (USD Billion, Tons)

  • 8.1 Key trends
  • 8.2 Direct Sales
  • 8.3 Pharmacies & Drugstores
  • 8.4 Health & Wellness Stores
  • 8.5 Supermarkets/Hypermarkets
  • 8.6 Online Retail
  • 8.7 Others

Chapter 9 Market Size and Forecast, By Region, 2021-2032 (USD Billion, Tons)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 South Korea
    • 9.4.5 Australia
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 MEA
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 South Africa
    • 9.6.4 Rest of MEA

Chapter 10 Company Profiles

  • 10.1 Indena S.p.A.
  • 10.2 Hangzhou GreenSky Biological Technology Co., Ltd
  • 10.3 Activ'Inside
  • 10.4 Xi'an Haoze Biotechnology Co., Ltd.
  • 10.5 Croda International Plc
  • 10.6 Actives Ltd
  • 10.7 LAC Global Pte. Ltd.